← All candidates
Five insider buys in the last year — $367.9K in all.
6 filings on record.
KMPRKEMPER Corp
NYSE · Financial Services · $1.60B
$27.25
-0.29% · Sep 15
Five insider buys in the last year — $367.9K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 5 buys◆ 1 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.60B
Float
54.9M
93% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
6.4
Price / sales
0.3
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Gorevic Jason N
Bought $129.6K on Aug 10 — 5,000 sh @ $25.91, held direct, 16% of their stake.
0 of 1 position beat the S&P
Director
Laderman Gerald
Bought $106.0K on Aug 11 — 4,000 sh @ $26.49, held direct, 12% of their stake.
0 of 1 position beat the S&P
President and CEO
McAnena Stephen J
Bought $79.5K on Aug 13 — 3,000 sh @ $26.50, held direct, 9.7% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$49.33 avg target
+81.0% vs today · 3 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26$0.45 act+$0.11
Q1 '26$0.21 act−$0.59
Q4 '25$0.25 act−$0.61
Q3 '25$0.33 act−$0.99
Coverage
The file stays open
6 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice